124 related articles for article (PubMed ID: 34699460)
41. Outcomes after induction failure in childhood acute lymphoblastic leukemia.
Schrappe M; Hunger SP; Pui CH; Saha V; Gaynon PS; Baruchel A; Conter V; Otten J; Ohara A; Versluys AB; Escherich G; Heyman M; Silverman LB; Horibe K; Mann G; Camitta BM; Harbott J; Riehm H; Richards S; Devidas M; Zimmermann M
N Engl J Med; 2012 Apr; 366(15):1371-81. PubMed ID: 22494120
[TBL] [Abstract][Full Text] [Related]
42. Long-Term Outcomes of Modified St Jude Children's Research Hospital Total Therapy XIIIB and XV Protocols for Thai Children With Acute Lymphoblastic Leukemia.
Surapolchai P; Anurathapan U; Sermcheep A; Pakakasama S; Sirachainan N; Songdej D; Pongpitcha P; Hongeng S
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):497-505. PubMed ID: 31103474
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia.
Eckert C; Biondi A; Seeger K; Cazzaniga G; Hartmann R; Beyermann B; Pogodda M; Proba J; Henze G
Lancet; 2001 Oct; 358(9289):1239-41. PubMed ID: 11675066
[TBL] [Abstract][Full Text] [Related]
44. Resource limited centres can deliver treatment for children with acute lymphoblastic leukaemia with risk-stratified minimal residual disease based UKALL 2003 protocol with no modification and a good outcome.
Lashkari HP; Faheem M; Sridevi Hanaganahalli B; Bhat KG; Joshi J; Kamath N; Ahlawat S; B P
Expert Rev Hematol; 2020 Oct; 13(10):1143-1151. PubMed ID: 32870048
[TBL] [Abstract][Full Text] [Related]
45. Outcome of children and adolescents with lymphoblastic lymphoma.
Oliveira MC; Sampaio KC; Oliveira AC; Santos AD; Castro LP; Viana MB
Rev Assoc Med Bras (1992); 2015; 61(5):417-22. PubMed ID: 26603004
[TBL] [Abstract][Full Text] [Related]
46. [Prognostic analysis of children with Philadelphia chromosome-like acute lymphoblastic leukemia common genes].
Hu WD; Li B; Su SF; Liu YF; Liu W; Zhang WL; Zuo WL; Yu RH
Zhonghua Er Ke Za Zhi; 2023 May; 61(5):446-452. PubMed ID: 37096265
[No Abstract] [Full Text] [Related]
47. Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy.
Pui CH; Pei D; Raimondi SC; Coustan-Smith E; Jeha S; Cheng C; Bowman WP; Sandlund JT; Ribeiro RC; Rubnitz JE; Inaba H; Gruber TA; Leung WH; Yang JJ; Downing JR; Evans WE; Relling MV; Campana D
Leukemia; 2017 Feb; 31(2):333-339. PubMed ID: 27560110
[TBL] [Abstract][Full Text] [Related]
48. Outcome of childhood acute lymphoblastic leukemia treatment in a single center in Brazil: A survival analysis study.
Bonilha TA; Obadia DDA; Valveson AC; Land MGP
Cancer Rep (Hoboken); 2022 Jan; 5(1):e1452. PubMed ID: 34114751
[TBL] [Abstract][Full Text] [Related]
49. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.
Wang Y; Zeng HM; Zhang LP
Ital J Pediatr; 2018 Aug; 44(1):94. PubMed ID: 30115129
[TBL] [Abstract][Full Text] [Related]
50. Relationship between minimal residual disease measured by multiparametric flow cytometry prior to allogeneic hematopoietic stem cell transplantation and outcome in children with acute lymphoblastic leukemia.
Elorza I; Palacio C; Dapena JL; Gallur L; Sánchez de Toledo J; Díaz de Heredia C
Haematologica; 2010 Jun; 95(6):936-41. PubMed ID: 20179088
[TBL] [Abstract][Full Text] [Related]
51. Use of simplified strategies to evaluate early treatment response in childhood acute lymphoblastic leukemia.
Scrideli CA; de Paula Queiróz R; Bernardes JE; Defavery R; Valera ET; Tone LG
Leuk Res; 2006 Aug; 30(8):1049-52. PubMed ID: 16406015
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
Wang YR; Jin RM; Xu JW; Xiao Y; Zhou DF; Zhang ZQ
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):1-4. PubMed ID: 18289459
[TBL] [Abstract][Full Text] [Related]
53. Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.
Schrappe M; Aricò M; Harbott J; Biondi A; Zimmermann M; Conter V; Reiter A; Valsecchi MG; Gadner H; Basso G; Bartram CR; Lampert F; Riehm H; Masera G
Blood; 1998 Oct; 92(8):2730-41. PubMed ID: 9763557
[TBL] [Abstract][Full Text] [Related]
54. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
Vora A; Goulden N; Wade R; Mitchell C; Hancock J; Hough R; Rowntree C; Richards S
Lancet Oncol; 2013 Mar; 14(3):199-209. PubMed ID: 23395119
[TBL] [Abstract][Full Text] [Related]
55. Survival Outcome of Filipino Children With Acute Lymphoblastic Leukemia Treated With Modified Berlin-Frankfurt-Muenster/Hong Kong Acute Lymphoblastic Leukemia (BFM95/HKALL97) Protocol in a Tertiary General Hospital From January 2005 to December 2009: A Retrospective Cohort Study.
Dujua AC; Hernandez FG
J Pediatr Hematol Oncol; 2017 Apr; 39(3):e116-e123. PubMed ID: 28085747
[TBL] [Abstract][Full Text] [Related]
56. Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.
Farkas T; Müller J; Erdelyi DJ; Csoka M; Kovacs GT
Pathol Oncol Res; 2017 Oct; 23(4):889-897. PubMed ID: 28138921
[TBL] [Abstract][Full Text] [Related]
57. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
58. Childhood and adolescent lymphoid and myeloid leukemia.
Pui CH; Schrappe M; Ribeiro RC; Niemeyer CM
Hematology Am Soc Hematol Educ Program; 2004; ():118-45. PubMed ID: 15561680
[TBL] [Abstract][Full Text] [Related]
59. ICU Admission in Children With Acute Lymphoblastic Leukemia in Sweden: Prevalence, Outcome, and Risk Factors.
Ranta S; Broman LM; Abrahamsson J; Berner J; Fläring U; Hed Myrberg I; Kalzén H; Karlsson L; Mellgren K; Nilsson A; Norén-Nyström U; Palle J; von Schewelov K; Svahn JE; Törnudd L; Heyman M; Harila-Saari A
Pediatr Crit Care Med; 2021 Dec; 22(12):1050-1060. PubMed ID: 34074998
[TBL] [Abstract][Full Text] [Related]
60. Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.
Ding Z; Han MZ; Chen SL; Ma QL; Wei JL; Pang AM; Zhang XY; Liang C; Yao JF; Cao YG; Feng SZ; Jiang EL
Chin Med J (Engl); 2015 Aug; 128(15):2065-71. PubMed ID: 26228220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
